10.2% of VTWV Holdings Seeing Recent Insider Buys

The Vanguard Russell 2000 Value (VTWV) ETF exhibits notable insider buying activity, with 10.2% of its weighted underlying holdings experiencing purchases over the past six months. This includes significant insider confidence in components like NBT Bancorp (NBTB), where three directors and officers bought shares totaling over $350,000, and Ligand Pharmaceuticals (LGND), which saw its CEO and CFO purchase shares exceeding $1.15 million, signaling a positive internal outlook for a segment of the small-cap value sector.

Analysis

The Vanguard Russell 2000 Value ETF (VTWV) is exhibiting a notable positive signal, with 10.2% of its weighted underlying holdings experiencing insider buying over the past six months. This suggests that corporate insiders across a segment of the small-cap value space perceive their companies' shares as undervalued. The trend is exemplified by specific holdings such as NBT Bancorp (NBTB), the ETF's #170 holding, where three directors and officers, including the President & CEO, collectively acquired over $358,000 in stock. Notably, these purchases were executed at prices ranging from $41.10 to $48.45, which are all above the stock's last trade price of $39.71, indicating strong conviction at higher valuations. Similarly, Ligand Pharmaceuticals (LGND), the #180 holding, saw its CEO and CFO make substantial purchases totaling over $1.15 million at prices around $104-$105, preceding the stock's rise to $114.07. While these individual companies each represent only 0.17% of the ETF, the breadth of insider buying across a tenth of the portfolio's assets points to a potentially bullish sentiment from those with the most intimate knowledge of these firms.

Key Decisions for Investors

• Investors may consider the insider buying across 10.2% of VTWV's holdings as a positive signal for the small-cap value segment, warranting a closer look at the ETF or its top components.